Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome
Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations ar...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 139; no. 6; pp. 1914 - 1922 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.06.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations are associated with the ALPS-like phenotype.
The aim of the present study was to elucidate the genetic cause of the ALPS-like phenotype.
Candidate genes associated with the ALPS-like phenotype were screened by using whole-exome sequencing. The functional effect of the identified mutations was examined by analyzing the activity of related signaling pathways.
A de novo heterozygous frameshift mutation of TNF-α–induced protein 3 (TNFAIP3, A20), a negative regulator of the nuclear factor κB pathway, was identified in one of the patients exhibiting the ALPS-like phenotype. Increased activity of the nuclear factor κB pathway was associated with haploinsufficiency of TNFAIP3 (A20).
Haploinsufficiency of TNFAIP3 (A20) by a germline heterozygous mutation leads to the ALPS phenotype. |
---|---|
AbstractList | Background Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations are associated with the ALPS-like phenotype. Objective The aim of the present study was to elucidate the genetic cause of the ALPS-like phenotype. Methods Candidate genes associated with the ALPS-like phenotype were screened by using whole-exome sequencing. The functional effect of the identified mutations was examined by analyzing the activity of related signaling pathways. Results Ade novoheterozygous frameshift mutation of TNF-α-induced protein 3 (TNFAIP3, A20), a negative regulator of the nuclear factor κB pathway, was identified in one of the patients exhibiting the ALPS-like phenotype. Increased activity of the nuclear factor κB pathway was associated with haploinsufficiency of TNFAIP3 (A20). Conclusion Haploinsufficiency of TNFAIP3 (A20) by a germline heterozygous mutation leads to the ALPS phenotype. Background Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations are associated with the ALPS-like phenotype. Objective The aim of the present study was to elucidate the genetic cause of the ALPS-like phenotype. Methods Candidate genes associated with the ALPS-like phenotype were screened by using whole-exome sequencing. The functional effect of the identified mutations was examined by analyzing the activity of related signaling pathways. Results A de novo heterozygous frameshift mutation of TNF-α–induced protein 3 (TNFAIP3, A20), a negative regulator of the nuclear factor κB pathway, was identified in one of the patients exhibiting the ALPS-like phenotype. Increased activity of the nuclear factor κB pathway was associated with haploinsufficiency of TNFAIP3 (A20). Conclusion Haploinsufficiency of TNFAIP3 (A20) by a germline heterozygous mutation leads to the ALPS phenotype. Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations are associated with the ALPS-like phenotype. The aim of the present study was to elucidate the genetic cause of the ALPS-like phenotype. Candidate genes associated with the ALPS-like phenotype were screened by using whole-exome sequencing. The functional effect of the identified mutations was examined by analyzing the activity of related signaling pathways. A de novo heterozygous frameshift mutation of TNF-α–induced protein 3 (TNFAIP3, A20), a negative regulator of the nuclear factor κB pathway, was identified in one of the patients exhibiting the ALPS-like phenotype. Increased activity of the nuclear factor κB pathway was associated with haploinsufficiency of TNFAIP3 (A20). Haploinsufficiency of TNFAIP3 (A20) by a germline heterozygous mutation leads to the ALPS phenotype. Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations are associated with the ALPS-like phenotype.BACKGROUNDAutoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric autoimmune disease caused by mutations in genes associated with the FAS-dependent apoptosis pathway. In addition, various genetic alterations are associated with the ALPS-like phenotype.The aim of the present study was to elucidate the genetic cause of the ALPS-like phenotype.OBJECTIVEThe aim of the present study was to elucidate the genetic cause of the ALPS-like phenotype.Candidate genes associated with the ALPS-like phenotype were screened by using whole-exome sequencing. The functional effect of the identified mutations was examined by analyzing the activity of related signaling pathways.METHODSCandidate genes associated with the ALPS-like phenotype were screened by using whole-exome sequencing. The functional effect of the identified mutations was examined by analyzing the activity of related signaling pathways.A de novo heterozygous frameshift mutation of TNF-α-induced protein 3 (TNFAIP3, A20), a negative regulator of the nuclear factor κB pathway, was identified in one of the patients exhibiting the ALPS-like phenotype. Increased activity of the nuclear factor κB pathway was associated with haploinsufficiency of TNFAIP3 (A20).RESULTSA de novo heterozygous frameshift mutation of TNF-α-induced protein 3 (TNFAIP3, A20), a negative regulator of the nuclear factor κB pathway, was identified in one of the patients exhibiting the ALPS-like phenotype. Increased activity of the nuclear factor κB pathway was associated with haploinsufficiency of TNFAIP3 (A20).Haploinsufficiency of TNFAIP3 (A20) by a germline heterozygous mutation leads to the ALPS phenotype.CONCLUSIONHaploinsufficiency of TNFAIP3 (A20) by a germline heterozygous mutation leads to the ALPS phenotype. |
Author | Shiraishi, Yuichi Chiba, Kenichi Ueno, Hiroo Ogawa, Seishi Muramatsu, Hideki Tanaka, Hiroko Miyano, Satoru Kojima, Seiji Yamashita, Motoy Okuno, Yusuke Hoshino, Akihiro Okano, Tsubasa Hayashi, Yasuhide Kajiwara, Michiko Kato, Motohiro Yeh, Tzuwen Ogata, Shohei Piao, Jinhua Yoshida, Kenichi Kanegane, Hirokazu Bando, Yuki Takagi, Masatoshi Imai, Kohsuke Morio, Tomohiro Nanya, Mai |
Author_xml | – sequence: 1 givenname: Masatoshi orcidid: 0000-0002-7580-9184 surname: Takagi fullname: Takagi, Masatoshi email: m.takagi.ped@tmd.ac.jp organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 2 givenname: Shohei surname: Ogata fullname: Ogata, Shohei organization: Department of Pediatrics, Kitasato University, Kanagawa, Japan – sequence: 3 givenname: Hiroo surname: Ueno fullname: Ueno, Hiroo organization: Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan – sequence: 4 givenname: Kenichi surname: Yoshida fullname: Yoshida, Kenichi organization: Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan – sequence: 5 givenname: Tzuwen surname: Yeh fullname: Yeh, Tzuwen organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 6 givenname: Akihiro surname: Hoshino fullname: Hoshino, Akihiro organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 7 givenname: Jinhua surname: Piao fullname: Piao, Jinhua organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 8 givenname: Motoy surname: Yamashita fullname: Yamashita, Motoy organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 9 givenname: Mai surname: Nanya fullname: Nanya, Mai organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 10 givenname: Tsubasa surname: Okano fullname: Okano, Tsubasa organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 11 givenname: Michiko surname: Kajiwara fullname: Kajiwara, Michiko organization: Department of Transfusion Medicine, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 12 givenname: Hirokazu surname: Kanegane fullname: Kanegane, Hirokazu organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 13 givenname: Hideki surname: Muramatsu fullname: Muramatsu, Hideki organization: Department of Pediatrics, Nagoya University, Nagoya, Japan – sequence: 14 givenname: Yusuke surname: Okuno fullname: Okuno, Yusuke organization: Department of Pediatrics, Nagoya University, Nagoya, Japan – sequence: 15 givenname: Yuichi surname: Shiraishi fullname: Shiraishi, Yuichi organization: Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – sequence: 16 givenname: Kenichi surname: Chiba fullname: Chiba, Kenichi organization: Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – sequence: 17 givenname: Hiroko surname: Tanaka fullname: Tanaka, Hiroko organization: Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – sequence: 18 givenname: Yuki surname: Bando fullname: Bando, Yuki organization: Department of Pediatrics, Kitasato University Medical Center, Saitama, Japan – sequence: 19 givenname: Motohiro surname: Kato fullname: Kato, Motohiro organization: Department of Pediatric Hematology and Oncology Research, National Centre for Child Health and Development, Tokyo, Japan – sequence: 20 givenname: Yasuhide surname: Hayashi fullname: Hayashi, Yasuhide organization: Gunma Children's Medical Center, Gunma, Japan – sequence: 21 givenname: Satoru surname: Miyano fullname: Miyano, Satoru organization: Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – sequence: 22 givenname: Kohsuke surname: Imai fullname: Imai, Kohsuke organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 23 givenname: Seishi surname: Ogawa fullname: Ogawa, Seishi organization: Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan – sequence: 24 givenname: Seiji surname: Kojima fullname: Kojima, Seiji organization: Department of Pediatrics, Nagoya University, Nagoya, Japan – sequence: 25 givenname: Tomohiro surname: Morio fullname: Morio, Tomohiro organization: Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27845235$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkt9r1TAUx4NM3N30H_BBCr7Mh9b8aNNERLiMzQ2GCs7nkKYnmmvb3CXthf73prtT4YLzKSfw-Z5z-H7PCToa_AAIvSS4IJjwt5tio40raKoLLAvMxBO0IljWORe0OkIrjCXJeV3KY3QS4wanPxPyGTqmtSgryqoV8ld623k3xMlaZxwMZs68zW4_Xa6vv7DsbE3xm6yZs-8Q-s4NkPXTqEfnh8zFzA073-2gTUWmp9G7vp8S0s399offBt85CyHRO8jiPLTB9_AcPbW6i_Di4T1F3y4vbs-v8pvPH6_P1ze54RiPucWWV1JQbSTmjHGJW6B1KQwtjQFWlWVTkYpYarmlpBG6sVVbmQQJywhgdorO9n3TGncTxFH1LhroOj2An6Iigsma1SUlCX19gG78FIa0nSISl4IRIWiiXj1QU9NDq7bB9TrM6reVCaB7wAQfYwD7ByFYLXmpjVryUkteCkuV8koicSAybu_vGLTrHpe-30sh2bhzEFS8zw9aF8CMqvXucfmHA7lJ-Tqju58wQ_xrgYpUYfV1uaXllAhnhArOU4N3_27wv-m_AH3d2HQ |
CitedBy_id | crossref_primary_10_1093_ckj_sfac130 crossref_primary_10_1297_cpe_28_91 crossref_primary_10_3390_ijms241612868 crossref_primary_10_3389_fimmu_2019_03022 crossref_primary_10_3389_fimmu_2021_629457 crossref_primary_10_1007_s10875_019_00695_4 crossref_primary_10_1016_j_autrev_2018_02_012 crossref_primary_10_1007_s40674_018_0093_3 crossref_primary_10_1007_s12519_019_00288_6 crossref_primary_10_1136_rmdopen_2018_000740 crossref_primary_10_1016_j_clim_2021_108853 crossref_primary_10_1002_JLB_2MR0520_166R crossref_primary_10_3389_fimmu_2021_671755 crossref_primary_10_3389_fimmu_2023_1127085 crossref_primary_10_1007_s10875_020_00792_9 crossref_primary_10_1016_j_jaci_2018_08_016 crossref_primary_10_3389_fimmu_2021_716469 crossref_primary_10_3390_jcm10081783 crossref_primary_10_1042_BCJ20210139 crossref_primary_10_1016_j_rhum_2018_09_012 crossref_primary_10_1111_bpa_12906 crossref_primary_10_3389_fimmu_2019_00101 crossref_primary_10_1007_s00105_020_04582_7 crossref_primary_10_3389_fimmu_2018_01892 crossref_primary_10_1007_s11882_019_0874_2 crossref_primary_10_1016_j_clim_2020_108441 crossref_primary_10_1097_BOR_0000000000000532 crossref_primary_10_1186_s41232_021_00159_6 crossref_primary_10_1002_gcc_22524 crossref_primary_10_5223_pghn_2023_26_4_201 crossref_primary_10_1038_s41556_019_0324_3 crossref_primary_10_1093_intimm_dxz024 crossref_primary_10_1136_annrheumdis_2017_212403 crossref_primary_10_12688_f1000research_11545_1 crossref_primary_10_3389_fimmu_2018_01527 crossref_primary_10_1016_j_jid_2023_12_007 crossref_primary_10_1186_s13075_019_1928_5 crossref_primary_10_1007_s11926_018_0749_x crossref_primary_10_1097_MPG_0000000000002796 crossref_primary_10_21508_1027_4065_2021_66_2_110_115 crossref_primary_10_1186_s12969_022_00735_1 crossref_primary_10_1016_j_jaci_2020_08_017 crossref_primary_10_3390_jcm9030712 crossref_primary_10_1080_08820139_2020_1829638 crossref_primary_10_4049_jimmunol_1801286 crossref_primary_10_1016_j_autrev_2024_103722 crossref_primary_10_1038_s41385_021_00398_3 crossref_primary_10_1111_liv_14935 crossref_primary_10_1016_j_jid_2018_06_191 crossref_primary_10_1080_14397595_2020_1719595 crossref_primary_10_1186_s12969_021_00558_6 crossref_primary_10_1007_s10875_024_01681_1 crossref_primary_10_1093_ibd_izy165 crossref_primary_10_1007_s00393_020_00794_3 crossref_primary_10_1007_s10875_019_00604_9 crossref_primary_10_3389_fimmu_2018_00104 crossref_primary_10_3390_ijms25158275 crossref_primary_10_1016_j_jaip_2023_04_018 crossref_primary_10_1097_MD_0000000000020232 crossref_primary_10_1007_s11882_018_0770_1 crossref_primary_10_3389_fimmu_2017_00399 crossref_primary_10_3389_fimmu_2021_827815 crossref_primary_10_1002_pbc_26831 crossref_primary_10_1186_s13075_021_02434_w crossref_primary_10_3389_fped_2023_1258301 crossref_primary_10_1016_j_jaci_2017_10_039 crossref_primary_10_1016_j_jbspin_2018_11_003 |
Cites_doi | 10.1182/blood-2010-08-301515 10.1038/ng.3040 10.1182/blood-2010-04-280347 10.1038/nm.3746 10.1126/science.1243292 10.1126/science.1255904 10.1007/s12026-013-8463-2 10.1016/j.ajhg.2012.04.015 10.1182/blood-2011-07-325217 10.1016/j.jaci.2016.03.022 10.1038/nature07969 10.1111/j.1365-3083.2011.02597.x 10.1126/science.289.5488.2350 10.1038/leu.2015.267 10.1182/blood-2012-12-469544 10.1038/ng.3459 10.1016/j.autrev.2016.07.011 10.1016/j.ajhg.2013.01.015 10.1038/sj.onc.1203238 10.1016/j.molcel.2011.09.015 10.1182/blood-2010-07-295501 10.1126/science.aaa1663 10.1182/blood-2014-02-553834 10.1385/CRIAI:20:1:109 10.1182/blood-2014-03-564286 10.1182/blood-2014-09-602763 10.1016/j.it.2013.10.005 |
ContentType | Journal Article |
Copyright | 2016 American Academy of Allergy, Asthma & Immunology American Academy of Allergy, Asthma & Immunology Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. Copyright Elsevier Science Ltd. Jun 1, 2017 |
Copyright_xml | – notice: 2016 American Academy of Allergy, Asthma & Immunology – notice: American Academy of Allergy, Asthma & Immunology – notice: Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Science Ltd. Jun 1, 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jaci.2016.09.038 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | Entomology Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 1922 |
ExternalDocumentID | 27845235 10_1016_j_jaci_2016_09_038 S0091674916312866 1_s2_0_S0091674916312866 |
Genre | Journal Article Case Reports |
GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development grantid: 27280301; 26070201 funderid: http://dx.doi.org/10.13039/100009619 |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM AACTN RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7SS 7T5 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c600t-f0f65982ac90633690de2748c24cce3544b5151f2f6f21b8abf5d5cde28f31e03 |
IEDL.DBID | .~1 |
ISSN | 0091-6749 1097-6825 |
IngestDate | Fri Jul 11 05:07:05 EDT 2025 Wed Aug 13 03:33:08 EDT 2025 Thu Apr 03 07:08:45 EDT 2025 Tue Jul 01 00:47:24 EDT 2025 Thu Apr 24 23:01:51 EDT 2025 Sun Apr 06 06:53:19 EDT 2025 Wed Apr 02 07:27:51 EDT 2025 Tue Aug 26 16:32:03 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | CASP WES IKK DNT MAPK TNFAIP3 (A20) ALPS GFP NF-κB Autoimmune lymphoproliferative syndrome TRAF6 NEMO WT TNF receptor–associated factor 6 Whole-exome sequencing Caspase Mitogen-activated protein kinase Wild-type IκB kinase NF-κB essential modulator Double-negative T Green fluorescent protein Nuclear factor κB |
Language | English |
License | Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c600t-f0f65982ac90633690de2748c24cce3544b5151f2f6f21b8abf5d5cde28f31e03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ORCID | 0000-0002-7580-9184 |
OpenAccessLink | http://www.jacionline.org/article/S0091674916312866/pdf |
PMID | 27845235 |
PQID | 1904831882 |
PQPubID | 105664 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1839737421 proquest_journals_1904831882 pubmed_primary_27845235 crossref_primary_10_1016_j_jaci_2016_09_038 crossref_citationtrail_10_1016_j_jaci_2016_09_038 elsevier_sciencedirect_doi_10_1016_j_jaci_2016_09_038 elsevier_clinicalkeyesjournals_1_s2_0_S0091674916312866 elsevier_clinicalkey_doi_10_1016_j_jaci_2016_09_038 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-06-01 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: St. Louis |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationTitleAlternate | J Allergy Clin Immunol |
PublicationYear | 2017 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Niemela, Lu, Fleisher, Davis, Caminha, Natter (bib4) 2011; 117 Catrysse, Vereecke, Beyaert, van Loo (bib23) 2014; 35 Oliveira, Bleesing, Dianzani, Fleisher, Jaffe, Lenardo (bib17) 2010; 116 Schubert, Bode, Kenefeck, Hou, Wing, Kennedy (bib13) 2014; 20 Angulo, Vadas, Garcon, Banham-Hall, Plagnol, Leahy (bib6) 2013; 342 Barkett, Gilmore (bib27) 1999; 18 Zhou, Wang, Schwartz, Stoffels, Park, Zhang (bib24) 2016; 48 Takagi, Shinoda, Piao, Mitsuiki, Takagi, Matsuda (bib3) 2011; 117 Rensing-Ehl, Volkl, Speckmann, Lorenz, Ritter, Janda (bib21) 2014; 124 Lo, Zhang, Lu, Zheng, Zhang, Kanellopoulou (bib11) 2015; 349 Skaug, Chen, Du, He, Ma, Chen (bib15) 2011; 44 Lee, Boone, Chai, Libby, Chien, Lodolce (bib22) 2000; 289 Fleisher, Puck, Strober, Dale, Lenardo, Siegel (bib2) 2001; 20 Elkaim, Neven, Bruneau, Mitsui-Sekinaka, Stanislas, Heurtier (bib7) 2016; 138 Patuzzo, Barbieri, Tinazzi, Veneri, Argentino, Moretta (bib20) 2016; 15 Kuehn, Niemela, Rangel-Santos, Zhang, Pittaluga, Stoddard (bib5) 2013; 121 Kunishima, Okuno, Yoshida, Shiraishi, Sanada, Muramatsu (bib16) 2013; 92 Saitoh, Hamano, Mochida, Kakeya, Uno, Tsuruyama (bib26) 2016; 30 Rao, Oliveira (bib1) 2011; 118 Flanagan, Haapaniemi, Russell, Caswell, Lango Allen, De Franco (bib8) 2014; 46 Neven, Bruneau, Stolzenberg, Meyts, Magerus-Chatinet, Moens (bib19) 2014; 124 Pujari, Hunte, Khan, Shembade (bib14) 2013; 57 Milner, Vogel, Forbes, Ma, Stray-Pedersen, Niemela (bib9) 2015; 125 Janda, Rensing-Ehl, Eibel, Ehl, Speckmann (bib18) 2011; 74 Kato, Sanada, Kato, Sato, Takita, Takeuchi (bib25) 2009; 459 Lopez-Herrera, Tampella, Pan-Hammarstrom, Herholz, Trujillo-Vargas, Phadwal (bib10) 2012; 90 Kuehn, Ouyang, Lo, Deenick, Niemela, Avery (bib12) 2014; 345 Skaug (10.1016/j.jaci.2016.09.038_bib15) 2011; 44 Takagi (10.1016/j.jaci.2016.09.038_bib3) 2011; 117 Kato (10.1016/j.jaci.2016.09.038_bib25) 2009; 459 Flanagan (10.1016/j.jaci.2016.09.038_bib8) 2014; 46 Janda (10.1016/j.jaci.2016.09.038_bib18) 2011; 74 Kuehn (10.1016/j.jaci.2016.09.038_bib5) 2013; 121 Patuzzo (10.1016/j.jaci.2016.09.038_bib20) 2016; 15 Kuehn (10.1016/j.jaci.2016.09.038_bib12) 2014; 345 Pujari (10.1016/j.jaci.2016.09.038_bib14) 2013; 57 Neven (10.1016/j.jaci.2016.09.038_bib19) 2014; 124 Rensing-Ehl (10.1016/j.jaci.2016.09.038_bib21) 2014; 124 Rao (10.1016/j.jaci.2016.09.038_bib1) 2011; 118 Milner (10.1016/j.jaci.2016.09.038_bib9) 2015; 125 Schubert (10.1016/j.jaci.2016.09.038_bib13) 2014; 20 Niemela (10.1016/j.jaci.2016.09.038_bib4) 2011; 117 Lopez-Herrera (10.1016/j.jaci.2016.09.038_bib10) 2012; 90 Barkett (10.1016/j.jaci.2016.09.038_bib27) 1999; 18 Angulo (10.1016/j.jaci.2016.09.038_bib6) 2013; 342 Catrysse (10.1016/j.jaci.2016.09.038_bib23) 2014; 35 Kunishima (10.1016/j.jaci.2016.09.038_bib16) 2013; 92 Fleisher (10.1016/j.jaci.2016.09.038_bib2) 2001; 20 Zhou (10.1016/j.jaci.2016.09.038_bib24) 2016; 48 Saitoh (10.1016/j.jaci.2016.09.038_bib26) 2016; 30 Elkaim (10.1016/j.jaci.2016.09.038_bib7) 2016; 138 Lee (10.1016/j.jaci.2016.09.038_bib22) 2000; 289 Lo (10.1016/j.jaci.2016.09.038_bib11) 2015; 349 Oliveira (10.1016/j.jaci.2016.09.038_bib17) 2010; 116 |
References_xml | – volume: 92 start-page: 431 year: 2013 end-page: 438 ident: bib16 article-title: ACTN1 mutations cause congenital macrothrombocytopenia publication-title: Am J Hum Genet – volume: 117 start-page: 2887 year: 2011 end-page: 2890 ident: bib3 article-title: Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation publication-title: Blood – volume: 125 start-page: 591 year: 2015 end-page: 599 ident: bib9 article-title: Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations publication-title: Blood – volume: 35 start-page: 22 year: 2014 end-page: 31 ident: bib23 article-title: A20 in inflammation and autoimmunity publication-title: Trends Immunol – volume: 118 start-page: 5741 year: 2011 end-page: 5751 ident: bib1 article-title: How I treat autoimmune lymphoproliferative syndrome publication-title: Blood – volume: 15 start-page: 877 year: 2016 end-page: 882 ident: bib20 article-title: Autoimmunity and infection in common variable immunodeficiency (CVID) publication-title: Autoimmun Rev – volume: 90 start-page: 986 year: 2012 end-page: 1001 ident: bib10 article-title: Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity publication-title: Am J Hum Genet – volume: 349 start-page: 436 year: 2015 end-page: 440 ident: bib11 article-title: Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy publication-title: Science – volume: 138 start-page: 210 year: 2016 end-page: 218.e9 ident: bib7 article-title: Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study publication-title: J Allergy Clin Immunol – volume: 121 start-page: 3117 year: 2013 end-page: 3125 ident: bib5 article-title: Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans publication-title: Blood – volume: 345 start-page: 1623 year: 2014 end-page: 1627 ident: bib12 article-title: Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 publication-title: Science – volume: 459 start-page: 712 year: 2009 end-page: 716 ident: bib25 article-title: Frequent inactivation of A20 in B-cell lymphomas publication-title: Nature – volume: 20 start-page: 109 year: 2001 end-page: 120 ident: bib2 article-title: The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis publication-title: Clin Rev Allergy Immunol – volume: 124 start-page: 851 year: 2014 end-page: 860 ident: bib21 article-title: Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency publication-title: Blood – volume: 48 start-page: 67 year: 2016 end-page: 73 ident: bib24 article-title: Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease publication-title: Nat Genet – volume: 117 start-page: 2883 year: 2011 end-page: 2886 ident: bib4 article-title: Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis publication-title: Blood – volume: 20 start-page: 1410 year: 2014 end-page: 1416 ident: bib13 article-title: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations publication-title: Nat Med – volume: 124 start-page: 1597 year: 2014 end-page: 1609 ident: bib19 article-title: Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients publication-title: Blood – volume: 289 start-page: 2350 year: 2000 end-page: 2354 ident: bib22 article-title: Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice publication-title: Science – volume: 57 start-page: 166 year: 2013 end-page: 171 ident: bib14 article-title: A20-mediated negative regulation of canonical NF-kappaB signaling pathway publication-title: Immunol Res – volume: 116 start-page: e35 year: 2010 end-page: e40 ident: bib17 article-title: Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop publication-title: Blood – volume: 44 start-page: 559 year: 2011 end-page: 571 ident: bib15 article-title: Direct, noncatalytic mechanism of IKK inhibition by A20 publication-title: Mol Cell – volume: 342 start-page: 866 year: 2013 end-page: 871 ident: bib6 article-title: Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage publication-title: Science – volume: 30 start-page: 716 year: 2016 end-page: 727 ident: bib26 article-title: A20 targets caspase-8 and FADD to protect HTLV-I-infected cells publication-title: Leukemia – volume: 46 start-page: 812 year: 2014 end-page: 814 ident: bib8 article-title: Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease publication-title: Nat Genet – volume: 74 start-page: 518 year: 2011 end-page: 519 ident: bib18 article-title: Elevated serum BAFF levels in patients with autoimmunity and lymphoproliferation publication-title: Scand J Immunol – volume: 18 start-page: 6910 year: 1999 end-page: 6924 ident: bib27 article-title: Control of apoptosis by Rel/NF-kappaB transcription factors publication-title: Oncogene – volume: 117 start-page: 2887 year: 2011 ident: 10.1016/j.jaci.2016.09.038_bib3 article-title: Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation publication-title: Blood doi: 10.1182/blood-2010-08-301515 – volume: 46 start-page: 812 year: 2014 ident: 10.1016/j.jaci.2016.09.038_bib8 article-title: Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease publication-title: Nat Genet doi: 10.1038/ng.3040 – volume: 116 start-page: e35 year: 2010 ident: 10.1016/j.jaci.2016.09.038_bib17 article-title: Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop publication-title: Blood doi: 10.1182/blood-2010-04-280347 – volume: 20 start-page: 1410 year: 2014 ident: 10.1016/j.jaci.2016.09.038_bib13 article-title: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations publication-title: Nat Med doi: 10.1038/nm.3746 – volume: 342 start-page: 866 year: 2013 ident: 10.1016/j.jaci.2016.09.038_bib6 article-title: Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage publication-title: Science doi: 10.1126/science.1243292 – volume: 345 start-page: 1623 year: 2014 ident: 10.1016/j.jaci.2016.09.038_bib12 article-title: Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 publication-title: Science doi: 10.1126/science.1255904 – volume: 57 start-page: 166 year: 2013 ident: 10.1016/j.jaci.2016.09.038_bib14 article-title: A20-mediated negative regulation of canonical NF-kappaB signaling pathway publication-title: Immunol Res doi: 10.1007/s12026-013-8463-2 – volume: 90 start-page: 986 year: 2012 ident: 10.1016/j.jaci.2016.09.038_bib10 article-title: Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2012.04.015 – volume: 118 start-page: 5741 year: 2011 ident: 10.1016/j.jaci.2016.09.038_bib1 article-title: How I treat autoimmune lymphoproliferative syndrome publication-title: Blood doi: 10.1182/blood-2011-07-325217 – volume: 138 start-page: 210 year: 2016 ident: 10.1016/j.jaci.2016.09.038_bib7 article-title: Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2016.03.022 – volume: 459 start-page: 712 year: 2009 ident: 10.1016/j.jaci.2016.09.038_bib25 article-title: Frequent inactivation of A20 in B-cell lymphomas publication-title: Nature doi: 10.1038/nature07969 – volume: 74 start-page: 518 year: 2011 ident: 10.1016/j.jaci.2016.09.038_bib18 article-title: Elevated serum BAFF levels in patients with autoimmunity and lymphoproliferation publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2011.02597.x – volume: 289 start-page: 2350 year: 2000 ident: 10.1016/j.jaci.2016.09.038_bib22 article-title: Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice publication-title: Science doi: 10.1126/science.289.5488.2350 – volume: 30 start-page: 716 year: 2016 ident: 10.1016/j.jaci.2016.09.038_bib26 article-title: A20 targets caspase-8 and FADD to protect HTLV-I-infected cells publication-title: Leukemia doi: 10.1038/leu.2015.267 – volume: 121 start-page: 3117 year: 2013 ident: 10.1016/j.jaci.2016.09.038_bib5 article-title: Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans publication-title: Blood doi: 10.1182/blood-2012-12-469544 – volume: 48 start-page: 67 year: 2016 ident: 10.1016/j.jaci.2016.09.038_bib24 article-title: Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease publication-title: Nat Genet doi: 10.1038/ng.3459 – volume: 15 start-page: 877 year: 2016 ident: 10.1016/j.jaci.2016.09.038_bib20 article-title: Autoimmunity and infection in common variable immunodeficiency (CVID) publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2016.07.011 – volume: 92 start-page: 431 year: 2013 ident: 10.1016/j.jaci.2016.09.038_bib16 article-title: ACTN1 mutations cause congenital macrothrombocytopenia publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2013.01.015 – volume: 18 start-page: 6910 year: 1999 ident: 10.1016/j.jaci.2016.09.038_bib27 article-title: Control of apoptosis by Rel/NF-kappaB transcription factors publication-title: Oncogene doi: 10.1038/sj.onc.1203238 – volume: 44 start-page: 559 year: 2011 ident: 10.1016/j.jaci.2016.09.038_bib15 article-title: Direct, noncatalytic mechanism of IKK inhibition by A20 publication-title: Mol Cell doi: 10.1016/j.molcel.2011.09.015 – volume: 117 start-page: 2883 year: 2011 ident: 10.1016/j.jaci.2016.09.038_bib4 article-title: Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis publication-title: Blood doi: 10.1182/blood-2010-07-295501 – volume: 349 start-page: 436 year: 2015 ident: 10.1016/j.jaci.2016.09.038_bib11 article-title: Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy publication-title: Science doi: 10.1126/science.aaa1663 – volume: 124 start-page: 1597 year: 2014 ident: 10.1016/j.jaci.2016.09.038_bib19 article-title: Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients publication-title: Blood doi: 10.1182/blood-2014-02-553834 – volume: 20 start-page: 109 year: 2001 ident: 10.1016/j.jaci.2016.09.038_bib2 article-title: The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis publication-title: Clin Rev Allergy Immunol doi: 10.1385/CRIAI:20:1:109 – volume: 124 start-page: 851 year: 2014 ident: 10.1016/j.jaci.2016.09.038_bib21 article-title: Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency publication-title: Blood doi: 10.1182/blood-2014-03-564286 – volume: 125 start-page: 591 year: 2015 ident: 10.1016/j.jaci.2016.09.038_bib9 article-title: Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations publication-title: Blood doi: 10.1182/blood-2014-09-602763 – volume: 35 start-page: 22 year: 2014 ident: 10.1016/j.jaci.2016.09.038_bib23 article-title: A20 in inflammation and autoimmunity publication-title: Trends Immunol doi: 10.1016/j.it.2013.10.005 |
SSID | ssj0009389 |
Score | 2.5108933 |
Snippet | Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized pediatric... Background Autoimmune diseases in children are rare and can be difficult to diagnose. Autoimmune lymphoproliferative syndrome (ALPS) is a well-characterized... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1914 |
SubjectTerms | Allergy and Immunology Apoptosis Autoimmune diseases Autoimmune lymphoproliferative syndrome Autoimmune Lymphoproliferative Syndrome - genetics Autoimmune Lymphoproliferative Syndrome - immunology Cells, Cultured Children Disease Fas antigen Frameshift mutation Functional anatomy Genomes Germ-Line Mutation Haploinsufficiency Humans Immunoglobulins Infant Kinases Leukocytes, Mononuclear - immunology Lymphocytes Male Mutation NF-kappa B - immunology Patients Pediatrics Phenotype Proteins Science Signal transduction TNFAIP3 (A20) Transcription Tumor Necrosis Factor alpha-Induced Protein 3 - genetics Tumor Necrosis Factor alpha-Induced Protein 3 - immunology |
Title | Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674916312866 https://www.clinicalkey.es/playcontent/1-s2.0-S0091674916312866 https://dx.doi.org/10.1016/j.jaci.2016.09.038 https://www.ncbi.nlm.nih.gov/pubmed/27845235 https://www.proquest.com/docview/1904831882 https://www.proquest.com/docview/1839737421 |
Volume | 139 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhdJL6bvbJkGFHlqKG-tlS8cldNm0ZOkhgdyEpZWKw9ZeuruFXPrbO2PZG0pe0IsxtoTFaDT6xjPziZD3rIiqrHyV6cIJcFCMzlwlZRa5coVxhsWO7PlkVkzP5Ndzdb5DjoZaGEyr7G1_sumdte6fHPbSPFzWNdb4Gkyhh4sAI1sg7baUJWr55z9XaR5G6ASBDcuwdV84k3K8LipfY3pXkbhO9W2b023gs9uEJk_I4x490nEa4FOyE5pn5OFJHx9_TtpptVy0mF_eMUNgWSVtIz2dTcbH3wX9MOb5R-ou6Q-wx4gv6c9NCsXTekXrBkzV7zCHG1pt1m2NpSOBLi5hwtslnu4TQ-IJpwPPwQtyNvlyejTN-iMVMg_IZp3FPBZI2Vd5A9hEgGs8D-CXas-l90EoKR0AHBZ5LCJnTlcuqrny0EhHwUIuXpLdpm3Ca0I1g-Wex9xL7SSPcx258QbdUedVIdmIsEGW1vd843jsxcIOiWUXFuVvUf42NxbkPyKftn2WiW3jztZimCI71JGC5bOwGdzZq7ypV1j1i3dlmV1xm9trCjYiatvzHx2994t7g_7Yq48YJPNn4OCMyLvta1jbGLCpmtBuoA2g11KUkoMwXyW924oFA8aKC_XmPwf1ljziiFC6H0p7ZHf9axP2AV-t3UG3gA7Ig_Hxt-nsL65hIk0 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dixMxEA_nCeqL-G311Ag-KLLe5rPJYzksPb0WH3pwb2GTJrJH3S22Fe7Fv92Z_egheif4siy7CRsmmclvdmZ-IeQN00kNi1BkRnsBDoo1mS-kzBJXXltvWWrInqczPTmVn87U2R456mthMK2ys_2tTW-sdffksJPm4aosscbXYgo9XAQYWa1vkJsS1BePMfjw8zLPwwrTYmDLMmzeVc60SV7nRSgxv0u3ZKfmqt3pKvTZ7ELje-RuBx_pqB3hfbIXqwfk1rQLkD8k9aRYLWtMMG-oIbCuktaJzmfj0fEXQd-OeP6O-gv6FQwyAkz6bdvG4mm5pmUFtupHXMANLbabusTakUiXFzDj9QqP90mxJQqnPdHBI3I6_jg_mmTdmQpZAGizyVKeNHL2FcECOBHgGy8iOKYmcBlCFEpKDwiHJZ504sybwie1UAEamSRYzMVjsl_VVXxKqGGg73nKgzRe8rQwidtg0R_1QWnJBoT1snShIxzHcy-Wrs8sO3cof4fyd7l1IP8Beb_rs2rpNq5tLfopcn0hKZg-B7vBtb2Gf-sV1532rh1za-5y98cKGxC16_nbIv3nFw_69eMuP2KRzZ-BhzMgr3evQbkxYlNUsd5CG4CvQzGUHIT5pF13O7FgxFhxoZ7956BekduT-fTEnRzPPj8ndzjClebv0gHZ33zfxhcAtjb-ZaNMvwAXUSPb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Haploinsufficiency+of+TNFAIP3+%28A20%29+by+germline+mutation+is+involved+in+autoimmune+lymphoproliferative+syndrome&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Takagi%2C+Masatoshi&rft.au=Ogata%2C+Shohei&rft.au=Ueno%2C+Hiroo&rft.au=Yoshida%2C+Kenichi&rft.date=2017-06-01&rft.pub=Elsevier+Inc&rft.issn=0091-6749&rft.volume=139&rft.issue=6&rft.spage=1914&rft.epage=1922&rft_id=info:doi/10.1016%2Fj.jaci.2016.09.038&rft.externalDocID=S0091674916312866 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon |